Specialty Pharmacy

Top news of the day from across the health care landscape.

Findings may lead to new targeted treatment options for HIV infection.

Prophylactic mastectomy for ovarian cancer survivors with BRCA mutations may not improve survival.

Hormone therapy is recommended to treat menopause symptoms, but is not recommended for breast cancer survivors.

The findings offer a new pathway for developing treatments for diseases such as amyotrophic lateral sclerosis.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Top news of the week from Specialty Pharmacy Times.

Treatments for hepatitis C, hemophilia, and cholesterol among specialty drugs approved for new indications this year.

Women who worked the night shift found to have a greater risk of developing breast cancer.

New ulcerative colitis and Crohn’s disease cases were uncommon in plaque psoriasis patients administered ixekizumab.

Top news of the day from across the health care landscape.

Study findings may improve treatment options for autoimmune disease.

Emicizumab prophylaxis is designed to bring together factors IXa and X to restore the blood clotting process.

Risk of death from MS higher among men in military across 3 successive decades.

Inhibiting heparanase observed to inhibit medulloblastoma cells.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses the importance of the treat-to target-strategy versus the non-targeted therapeutic approach in patients with rheumatoid arthritis.

HIV rebound detected within 1 day before delivery in 50% of study participants.

Top news of the day from across the health care landscape.

A first-in-class selective retinoic acid receptor alpha agonist is being tested in phase 2 clinical trials for acute myeloid leukemia and myelodysplastic syndrome.

Drugs that treat autoimmune disorders and hepatitis C virus power specialty drug spending.

Lebrikizumab is a monoclonal antibody designed to treat atopic dermatitis.

T cell responses in different tumor models are fundamentally similar.

Changes include additional trial data in virologically-suppressed adults with HIV-1 infection.

Brandon Shank, PharmD, MPH, BCOP, discusses how pharmacists work with patients undergoing chemotherapy through transitions of care.

It may be possible to retrain the immune system to prevent or slow attacks on insulin-producing beta cells.

Baby boomer hepatitis C virus screening rates spiked when a prompt in their electronic health records reminded a primary care provider to recommend testing.

Patients who have received a transplant and are non-adherent to their medication regimens are more likely to experience graft failure and higher health care costs.

Marc O’Connor, chief operating officer at Curant Health, explains why treating the whole patient rather than just their specific disease is so important.